Zobrazeno 1 - 10 of 138 pro vyhledávání: '"Julin CH"'
1
Akademický článek
Why were so few randomized trials of public health and social measures conducted during the COVID-19 pandemic? The Norwegian experience.
Autor: Fretheim A; Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Oslo, Norway. atle.fretheim@fhi.no., Elstrøm P; Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Oslo, Norway., Julin CH; Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Oslo, Norway., Gopinathan U; Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Oslo, Norway., Elgersma IH; Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Oslo, Norway., Solberg RB; Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Oslo, Norway., Helleve A; Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Oslo, Norway.; Centre for Evaluation of Public Health Measures, Norwegian Institute of Public Health, Oslo, Norway.
Publikováno v: Trials [Trials] 2024 Oct 12; Vol. 25 (1), pp. 673. Date of Electronic Publication: 2024 Oct 12.
Zobrazit plný text záznamu
2
Akademický článek
Susceptibility and infectiousness of SARS-CoV-2 in children versus adults, by variant (wild-type, alpha, delta): A systematic review and meta-analysis of household contact studies.
Autor: Uthman OA; Warwick Centre for Global Health, Warwick Medical School, University of Warwick, Coventry, United Kingdom., Lyngse FP; Department of Economics & Center for Economic Behaviour and Inequality, University of Copenhagen, Copenhagen, Denmark., Anjorin S; Warwick Centre for Global Health, Warwick Medical School, University of Warwick, Coventry, United Kingdom., Hauer B; Department for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany., Hakki S; NIHR Health Protection Research Unit in Respiratory Infections, National Heart and Lung Institute, Imperial College London, London, United Kingdom., Martinez DA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.; School of Industrial Engineering, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile., Ge Y; School of Health Professions, University of Southern Mississippi, Hattiesburg, Mississippi, United States of America., Jonnerby J; School of Public Health, Imperial College London, London, United Kingdom., Julin CH; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Lin G; Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America., Lalvani A; NIHR Health Protection Research Unit in Respiratory Infections, National Heart and Lung Institute, Imperial College London, London, United Kingdom., Loss J; Department of Epidemiology and Health Monitoring, Robert Koch-Institute, Berlin, Germany., Madon KJ; NIHR Health Protection Research Unit in Respiratory Infections, National Heart and Lung Institute, Imperial College London, London, United Kingdom., Martinez L; Department of Epidemiology, Boston University School of Public Health, Boston, MA, United States of America., Næss LM; School of Public Health, Imperial College London, London, United Kingdom., Page KR; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America., Prieto D; School of Industrial Engineering, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile., Robertson AH; School of Public Health, Imperial College London, London, United Kingdom., Shen Y; Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, GA, United States of America., Wurm J; Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America., Buchholz U; Department for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany.
Publikováno v: PloS one [PLoS One] 2024 Sep 06; Vol. 19 (9), pp. e0306740. Date of Electronic Publication: 2024 Sep 06 (Print Publication: 2024).
Zobrazit plný text záznamu
3
Akademický článek
Receipt of hepatitis E vaccine and fetal loss in rural Bangladesh: further analysis of a double-blind, cluster-randomised, controlled trial.
Autor: Aziz AB; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh; International Vaccine Institute, Seoul, South Korea; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Electronic address: asma.aziz@ivi.int., Dudman S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Oslo University Hospital, Oslo, Norway., Julin CH; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Ahmmed F; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Stene-Johansen K; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Sandbu S; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Øverbø J; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Dembinski JL; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Wisløff T; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Rana S; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Basunia AH; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Haque W; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Qadri F; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Zaman K; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Clemens JD; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh; International Vaccine Institute, Seoul, South Korea; UCLA Fielding School of Public Health, University of California, Los Angeles, CA, USA; Korea University Vaccine Innovation Center, Seoul, South Korea.
Publikováno v: The Lancet. Global health [Lancet Glob Health] 2024 Aug; Vol. 12 (8), pp. e1300-e1311.
Zobrazit plný text záznamu
4
Akademický článek
Safety and effectiveness of a recombinant hepatitis E vaccine in women of childbearing age in rural Bangladesh: a phase 4, double-blind, cluster-randomised, controlled trial.
Autor: Zaman K; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Julin CH; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Aziz AB; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; International Vaccine Institute, Seoul, South Korea., Stene-Johansen K; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Yunus M; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Qadri F; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Gurley ES; Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA., Sandbu S; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Øverbø J; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Dembinski JL; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Laake I; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Bhuiyan TR; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Rahman M; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Haque W; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Khanam M; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Clemens JD; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh; Jonathan and Karin Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA., Dudman S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Oslo University Hospital, Oslo, Norway. Electronic address: susannmg@medisin.uio.no.
Publikováno v: The Lancet. Global health [Lancet Glob Health] 2024 Aug; Vol. 12 (8), pp. e1288-e1299.
Zobrazit plný text záznamu
5
Akademický článek
Hepatitis E Virus (HEV) Synopsis: General Aspects and Focus on Bangladesh.
Autor: Aziz AB; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.; International Vaccine Institute (IVI), Seoul 08800, Republic of Korea., Øverbø J; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.; Norwegian Institute of Public Health (NIPH), Division of Infection Control and Environmental Health, 0213 Oslo, Norway., Dudman S; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway., Julin CH; Norwegian Institute of Public Health (NIPH), Division of Infection Control and Environmental Health, 0213 Oslo, Norway., Kwon YJG; Carnegie Mellon University, Pittsburgh, PA 15213, USA., Jahan Y; Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-0046, Japan., Ali M; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, MD 21205, USA., Dembinski JL; Norwegian Institute of Public Health (NIPH), Division of Infection Control and Environmental Health, 0213 Oslo, Norway.
Publikováno v: Viruses [Viruses] 2022 Dec 24; Vol. 15 (1). Date of Electronic Publication: 2022 Dec 24.
Zobrazit plný text záznamu
6
Akademický článek
Stability and Feasibility of Dried Blood Spots for Hepatitis E Virus Serology in a Rural Setting.
Autor: Øverbø J; Norwegian Institute of Public Health, NO-0213 Oslo, Norway.; Department of Microbiology, Institute of Clinical Medicine, University of Oslo, NO-0424 Oslo, Norway., Aziz A; Department of Microbiology, Institute of Clinical Medicine, University of Oslo, NO-0424 Oslo, Norway.; International Centre for Diarrheal Diseases Research, Dhaka 1212, Bangladesh.; International Vaccine Institute, Seoul 08826, Republic of Korea., Zaman K; International Centre for Diarrheal Diseases Research, Dhaka 1212, Bangladesh., Julin CH; Norwegian Institute of Public Health, NO-0213 Oslo, Norway., Qadri F; International Centre for Diarrheal Diseases Research, Dhaka 1212, Bangladesh., Stene-Johansen K; Norwegian Institute of Public Health, NO-0213 Oslo, Norway., Biswas R; International Centre for Diarrheal Diseases Research, Dhaka 1212, Bangladesh., Islam S; International Centre for Diarrheal Diseases Research, Dhaka 1212, Bangladesh., Bhuiyan TR; International Centre for Diarrheal Diseases Research, Dhaka 1212, Bangladesh., Haque W; International Centre for Diarrheal Diseases Research, Dhaka 1212, Bangladesh., Sandbu S; Norwegian Institute of Public Health, NO-0213 Oslo, Norway., Dembinski JL; Norwegian Institute of Public Health, NO-0213 Oslo, Norway., Dudman S; Department of Microbiology, Institute of Clinical Medicine, University of Oslo, NO-0424 Oslo, Norway.; Oslo University Hospital, NO-0424 Oslo, Norway.
Publikováno v: Viruses [Viruses] 2022 Nov 15; Vol. 14 (11). Date of Electronic Publication: 2022 Nov 15.
Zobrazit plný text záznamu
7
Akademický článek
Household Transmission of SARS-CoV-2: A Prospective Longitudinal Study Showing Higher Viral Load and Increased Transmissibility of the Alpha Variant Compared to Previous Strains.
Autor: Julin CH; Division of Infection Control, Norwegian Institute of Public Health, P.O. Box 222 Skøyen, 0213 Oslo, Norway., Robertson AH; Division of Infection Control, Norwegian Institute of Public Health, P.O. Box 222 Skøyen, 0213 Oslo, Norway., Hungnes O; Division of Infection Control, Norwegian Institute of Public Health, P.O. Box 222 Skøyen, 0213 Oslo, Norway., Tunheim G; Division of Infection Control, Norwegian Institute of Public Health, P.O. Box 222 Skøyen, 0213 Oslo, Norway., Bekkevold T; Division of Infection Control, Norwegian Institute of Public Health, P.O. Box 222 Skøyen, 0213 Oslo, Norway., Laake I; Division of Infection Control, Norwegian Institute of Public Health, P.O. Box 222 Skøyen, 0213 Oslo, Norway., Aune IF; Division of Infection Control, Norwegian Institute of Public Health, P.O. Box 222 Skøyen, 0213 Oslo, Norway., Killengreen MF; Division of Infection Control, Norwegian Institute of Public Health, P.O. Box 222 Skøyen, 0213 Oslo, Norway., Strand TR; Division of Infection Control, Norwegian Institute of Public Health, P.O. Box 222 Skøyen, 0213 Oslo, Norway., Rykkvin R; Division of Infection Control, Norwegian Institute of Public Health, P.O. Box 222 Skøyen, 0213 Oslo, Norway., Dorenberg DH; Division of Infection Control, Norwegian Institute of Public Health, P.O. Box 222 Skøyen, 0213 Oslo, Norway., Stene-Johansen K; Division of Infection Control, Norwegian Institute of Public Health, P.O. Box 222 Skøyen, 0213 Oslo, Norway., Berg ES; Division of Infection Control, Norwegian Institute of Public Health, P.O. Box 222 Skøyen, 0213 Oslo, Norway., Bodin JE; Division of Infection Control, Norwegian Institute of Public Health, P.O. Box 222 Skøyen, 0213 Oslo, Norway., Oftung F; Division of Infection Control, Norwegian Institute of Public Health, P.O. Box 222 Skøyen, 0213 Oslo, Norway., Steens A; Division of Infection Control, Norwegian Institute of Public Health, P.O. Box 222 Skøyen, 0213 Oslo, Norway., Næss LM; Division of Infection Control, Norwegian Institute of Public Health, P.O. Box 222 Skøyen, 0213 Oslo, Norway.
Publikováno v: Microorganisms [Microorganisms] 2021 Nov 17; Vol. 9 (11). Date of Electronic Publication: 2021 Nov 17.
Zobrazit plný text záznamu
8
Akademický článek
HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh.
Autor: Zaman K; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh kzaman@icddrb.org., Dudman S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway., Stene-Johansen K; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway., Qadri F; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh., Yunus M; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh., Sandbu S; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway., Gurley ES; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh.; Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA., Overbo J; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway., Julin CH; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway., Dembinski JL; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway., Nahar Q; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh., Rahman A; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh., Bhuiyan TR; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh., Rahman M; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh., Haque W; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh., Khan J; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh.; Health Economics, Liverpool School of Tropical Medicine, Liverpool, UK., Aziz A; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh., Khanam M; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh., Streatfield PK; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh., Clemens JD; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh.; University of California Los Angeles Jonathan and Karin Fielding School of Public Health, Los Angeles, California, USA.
Publikováno v: BMJ open [BMJ Open] 2020 Jan 19; Vol. 10 (1), pp. e033702. Date of Electronic Publication: 2020 Jan 19.
Zobrazit plný text záznamu
9
Akademický článek
Hepatitis E virus in the Kathmandu Valley: Insights from a representative longitudinal serosurvey.
Autor: Katuwal, Nishan1,2 (AUTHOR), Thapa, Melina1 (AUTHOR), Shrestha, Sony1 (AUTHOR), Vaidya, Krista1,3 (AUTHOR), Bogoch, Isaac I.4 (AUTHOR), Shrestha, Rajeev1,2 (AUTHOR), Andrews, Jason R.5 (AUTHOR), Tamrakar, Dipesh1,2,6 (AUTHOR), Aiemjoy, Kristen3,7 (AUTHOR) kaiemjoy@ucdavis.edu
Publikováno v: PLoS Neglected Tropical Diseases. 8/5/2024, Vol. 18 Issue 8, p1-14. 14p.
Zobrazit plný text záznamu
10
Akademický článek
Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer.
Autor: Ci, Xinpei1 (AUTHOR), Chen, Sujun1,2 (AUTHOR), Zhu, Rui1 (AUTHOR), Zarif, Mojgan1 (AUTHOR), Jain, Rahi1 (AUTHOR), Guo, Wangyuan1 (AUTHOR), Ramotar, Matthew1 (AUTHOR), Gong, Linsey1,3 (AUTHOR), Xu, Wenjie4 (AUTHOR), Singh, Olivia1 (AUTHOR), Mansouri, Sheila1 (AUTHOR), Zadeh, Gelareh1,5 (AUTHOR), Wei, Gong-Hong4 (AUTHOR), Xu, Wei1 (AUTHOR), Bristow, Robert6,7 (AUTHOR), Berlin, Alejandro1 (AUTHOR) alejandro.berlin@rmp.uhn.ca, Koritzinsky, Marianne1,3,8,9 (AUTHOR) marianne.koritzinsky@uhnresearch.ca, van der Kwast, Theodorus1,10 (AUTHOR) theodorus.vanderkwast@uhn.ca, He, Housheng Hansen1,3 (AUTHOR) hansenhe@uhnresearch.ca
Publikováno v: BMC Cancer. 6/18/2024, Vol. 24 Issue 1, p1-12. 12p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje